drugset / Trial / NCT01702675
Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is evaluate the safety and tolerability parameters regarding the new drug in healthy men and evaluate the pharmacokinetics parameters after one dose and multiple doses of the new drug.
Timeline
- Start
- 2015-05
- Primary completion
- 2017-04
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACH15 | Unknown | 50 mg | Oral |
| Subject | ACH15 | Unknown | 250 mg | Oral |
| Subject | ACH15 | Unknown | 500 mg | Oral |
| Subject | ACH15 | Unknown | 1000 mg | Oral |
| Subject | ACH15 | Unknown | 2000 mg | Oral |
Indications
No indication recorded.